BindingDB logo
myBDB logout

Patent code US10561657

Compile Data Set for Download or QSAR
Found 26 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM433345
PNG
(US10561657, Example 26)
Show SMILES NCCNC(=O)c1nn(cc1-c1ncnc2[nH]ccc12)C(CC#N)C1CCCC1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a<20n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM433332
PNG
(US10561657, Example 11)
Show SMILES N#CCC(C1CCCC1)n1cc(c(NCCN2CCOCC2)n1)-c1ncnc2[nH]ccc12
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a<20n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM433323
PNG
(US10561657, Ruxolitinib | US10617692, Ruxolitinib)
Show SMILES N#CCC(C1CCCC1)n1cc(cn1)-c1ncnc2[nH]ccc12
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a<20n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM433329
PNG
(US10561657, Example 7)
Show SMILES CCNc1nn(cc1-c1ncnc2[nH]ccc12)C(CC#N)C1CCCC1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a<20n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM433331
PNG
(US10561657, Example 10)
Show SMILES CS(=O)(=O)Nc1nn(cc1-c1ncnc2[nH]ccc12)C(CC#N)C1CCCC1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a<20n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM433333
PNG
(US10561657, Example 12)
Show SMILES O=C(CN1CCOCC1)Nc1nn(cc1-c1ncnc2[nH]ccc12)C(CC#N)C1CCCC1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a<20n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM433340
PNG
(US10561657, Example 17)
Show SMILES O=C(C1CC(C1)Nc1nn(cc1-c1ncnc2[nH]ccc12)C(CC#N)C1CCCC1)N1CCOCC1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a<20n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM433327
PNG
(US10561657, Example 5)
Show SMILES Nc1nn(cc1-c1ncnc2[nH]ccc12)[C@H](CC#N)C1CCCC1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a<20n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM433330
PNG
(US10561657, Example 9)
Show SMILES CC(=O)Nc1nn(cc1-c1ncnc2[nH]ccc12)C(CC#N)C1CCCC1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a<20n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM433335
PNG
(US10561657, Example 13)
Show SMILES O=C(CCNc1nn(cc1-c1ncnc2[nH]ccc12)C(CC#N)C1CCCC1)N1CCOCC1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a<20n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM433342
PNG
(US10561657, Example 19)
Show SMILES Brc1nn(cc1-c1ncnc2[nH]ccc12)C(CC#N)C1CCCC1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a<20n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM433344
PNG
(US10561657, Example 25)
Show SMILES CNC(=O)c1nn(cc1-c1ncnc2[nH]ccc12)C(CC#N)C1CCCC1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a<20n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2 (V617F)


(Homo sapiens (Human))
BDBM433329
PNG
(US10561657, Example 7)
Show SMILES CCNc1nn(cc1-c1ncnc2[nH]ccc12)C(CC#N)C1CCCC1
PDB

UniProtKB/TrEMBL

GoogleScholar
UniChem
US Patent
n/an/a<20n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM433338
PNG
(US10561657, Example 15)
Show SMILES CCOC(=O)CCC(=O)Nc1nn(cc1-c1ncnc2[nH]ccc12)C(CC#N)C1CCCC1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a<20n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM433348
PNG
(US10561657, Example 28)
Show SMILES OCc1nn(cc1-c1ncnc2[nH]ccc12)C(CC#N)C1CCCC1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a<20n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM433324
PNG
(US10561657, Example 1)
Show SMILES Nc1nn(cc1-c1ncnc2[nH]ccc12)C(CC#N)C1CCCC1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a<20n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM433336
PNG
(US10561657, Example 14)
Show SMILES O=C(CNc1nn(cc1-c1ncnc2[nH]ccc12)C(CC#N)C1CCCC1)N1CCOCC1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a<20n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM433346
PNG
(US10561657, Example 27)
Show SMILES N#CCC(C1CCCC1)n1cc(c(n1)C#N)-c1ncnc2[nH]ccc12
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a<20n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2 (V617F)


(Homo sapiens (Human))
BDBM433323
PNG
(US10561657, Ruxolitinib | US10617692, Ruxolitinib)
Show SMILES N#CCC(C1CCCC1)n1cc(cn1)-c1ncnc2[nH]ccc12
PDB

UniProtKB/TrEMBL

GoogleScholar
UniChem
US Patent
n/an/a<20n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2 (V617F)


(Homo sapiens (Human))
BDBM433324
PNG
(US10561657, Example 1)
Show SMILES Nc1nn(cc1-c1ncnc2[nH]ccc12)C(CC#N)C1CCCC1
PDB

UniProtKB/TrEMBL

GoogleScholar
UniChem
US Patent
n/an/a<20n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM433326
PNG
(US10561657, Example 3)
Show SMILES Nc1c(cnn1C(CC#N)C1CCCC1)-c1ncnc2[nH]ccc12
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a<20n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM433328
PNG
(US10561657, Example 6)
Show SMILES Nc1nn(cc1-c1ncnc2[nH]ccc12)[C@@H](CC#N)C1CCCC1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a<20n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM433343
PNG
(US10561657, Example 24)
Show SMILES NC(=O)c1nn(cc1-c1ncnc2[nH]ccc12)C(CC#N)C1CCCC1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a<20n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM433325
PNG
(US10561657, Example 2)
Show SMILES NC(=O)CC(C1CCCC1)n1cc(c(N)n1)-c1ncnc2[nH]ccc12
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a<100n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM433339
PNG
(US10561657, Example 16)
Show SMILES O=C1CCC(=O)N1c1nn(cc1-c1ncnc2[nH]ccc12)C(CC#N)C1CCCC1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a<100n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM433341
PNG
(US10561657, Example 18)
Show SMILES Brc1nn(cc1-c1ncnc2[nH]cc(Br)c12)C(CC#N)C1CCCC1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



Centaurus Biophrama Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Lianyungang Runzhong Pharmaceutical Co., Ltd.

US Patent


Assay Description
A testing platform for kinase activity of JAK2 (wild type and V617F mutant type) was established based on Homogeneous Time-Resolved Fluorescence (HTR...


US Patent US10561657 (2020)


BindingDB Entry DOI: 10.7270/Q2TX3HRK
More data for this
Ligand-Target Pair
* indicates data uncertainty>20%